Where does Ojai Retinal Technology, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ojai Retinal Technology, LLC ranks #10,126 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ojai Retinal Technology, LLC hold?

Ojai Retinal Technology, LLC holds 31 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is Ojai Retinal Technology, LLC's Innovation Score?

Ojai Retinal Technology, LLC has an Innovation Score of 30.4 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ojai Retinal Technology, LLC's patent grant rate increasing or decreasing?

Ojai Retinal Technology, LLC's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ojai Retinal Technology, LLC's patents?

Ojai Retinal Technology, LLC's patents average 20.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ojai Retinal Technology, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ojai Retinal Technology, LLC

Q: What technology areas does Ojai Retinal Technology, LLC focus on?

Ojai Retinal Technology, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 28 patents, ranking #234 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 31 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ojai ranks #10,126 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 3 technology areas.

#10,126
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.4/100): 20.1
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10126 · US Corporation #10,126 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #10,126/49,997
PHOTO-FINISH Nytell Software
CPC-NARROW A61F · 3 areas
INNOV-THIN 30.4/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nytell Software LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ojai’s 30.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (39%) Velocity 0.3 pts (1%) Breadth 6.1 pts (20%) Claim depth 12.0 pts (39%)

Qualcomm Incorporated · highest

85
Daiwa Kasei Industry · near

30
Exact Sciences… · near

30
Ojai Retinal… · this assignee

30
SugarCRM · near

30
Valentino S p A · near

30
3D Lighting… · lowest

7

What this shows Ojai's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ojai?

Each dot is one of Ojai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ojai’s own 20.1 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ojai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ojai's grants concentrate

Ojai Retinal Technology, LLC is a focused PatentsView assignee: 3 CPC subclasses with 90.3% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (11 grants) versus a trough of 1 in 2015. By volume, Ojai sits between Nytell Software LLC and PPC Broadband Fiber Ltd..

Ojai's three-year grant acceleration

From 2019–2021 to 2022–2024, Ojai Retinal Technology, LLC moved from 22 to 1 grants (0.04x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Nytell Software

31
Octapharma

31
OCV Intellectual…

31
Organovo

31
Orbbec

31
PIC

31
PMC Industries

31
PPC Broadband Fib…

31
Ojai Retinal Tech… ◀

31

What this shows Ojai holds 31 patents at rank #10,127, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ojai

By rank, the assignees closest to #10,127 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ojai's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ojai, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Ojai ranks #234 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Exact Sciences Development Company, LLC 30 SugarCRM, Inc. 30 Valentino S.p.A. 30 Daiwa Kasei Industry Co., Ltd. 30

Ojai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ojai Retinal Technology, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.2%
2016	3	9.7%
2018	3	9.7%
2019	11	35.5%
2020	5	16.1%
2021	6	19.4%
2023	1	3.2%
2025partial year	1	3.2%

Which technologies does Ojai Retinal Technology, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 28

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 26

A61B - DIAGNOSIS; SURGERY; Identification 25

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ojai Retinal Technology, LLC's patent record in context - here's where to go next.

Ojai Retinal Technology, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 90.3% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #10,126 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ojai Retinal Technology, LLC against Nytell Software LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.